Akt activation in renal cell carcinoma

Contribution of a decreased PTEN expression and the induction of apoptosis by an Akt inhibitor

S. Hara, Mototsugu Oya, Ryuichi Mizuno, A. Horiguchi, K. Marumo, M. Murai

Research output: Contribution to journalArticle

81 Citations (Scopus)

Abstract

Background: Akt has been implicated in the oncogenesis of human malignant tumors, because Akt regulates many key effector molecules involved in cell survival. PTEN (phosphatase and tensin homolog deleted on chromosome 10) negatively regulates Akt activation. Materials and methods: The expression of phosphorylated Akt (p-Akt), total Akt and PTEN was analyzed by Western blotting in 45 renal cell carcinoma (RCC) patients. The Bad and phosphorylated Bad (p-Bad) statuses were analyzed in 20 RCC patients. A phosphatidylinositol ether analog was used as an Akt inhibitor to treat four RCC cell lines, namely Caki-1, KU19-20, SW839 and Caki-2. Results: The PTEN expression in RCC was observed to decrease and p-Akt expression to increase significantly in comparison with that in the corresponding normal kidney tissue. The PTEN expression inversely correlated with the p-Akt expression. These alterations were specific for clear cell type RCC, but not for papillary or chromophobe type RCC. Alterations in Bad phosphorylation were also specifically observed in clear cell type. The Akt inhibitor induced apoptosis in KU19-20 and Caki-2 cells with a high Akt activity. Conclusions: A decreased expression of PTEN may be an underlying mechanism for Akt activation. An Akt inhibitor may be a therapeutic option for a subset of RCC with an elevated Akt activity.

Original languageEnglish
Pages (from-to)928-933
Number of pages6
JournalAnnals of Oncology
Volume16
Issue number6
DOIs
Publication statusPublished - 2005 Jun

Fingerprint

Renal Cell Carcinoma
Apoptosis
PTEN Phosphohydrolase
Chromosomes, Human, Pair 10
Phosphatidylinositols
Ether
Cell Survival
Carcinogenesis
Western Blotting
Phosphorylation
Kidney
Cell Line
Neoplasms

Keywords

  • Akt
  • Bad
  • PTEN
  • Renal cell carcinoma

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Akt activation in renal cell carcinoma : Contribution of a decreased PTEN expression and the induction of apoptosis by an Akt inhibitor. / Hara, S.; Oya, Mototsugu; Mizuno, Ryuichi; Horiguchi, A.; Marumo, K.; Murai, M.

In: Annals of Oncology, Vol. 16, No. 6, 06.2005, p. 928-933.

Research output: Contribution to journalArticle

@article{72881202f31f4c18b1ff10ca146a5106,
title = "Akt activation in renal cell carcinoma: Contribution of a decreased PTEN expression and the induction of apoptosis by an Akt inhibitor",
abstract = "Background: Akt has been implicated in the oncogenesis of human malignant tumors, because Akt regulates many key effector molecules involved in cell survival. PTEN (phosphatase and tensin homolog deleted on chromosome 10) negatively regulates Akt activation. Materials and methods: The expression of phosphorylated Akt (p-Akt), total Akt and PTEN was analyzed by Western blotting in 45 renal cell carcinoma (RCC) patients. The Bad and phosphorylated Bad (p-Bad) statuses were analyzed in 20 RCC patients. A phosphatidylinositol ether analog was used as an Akt inhibitor to treat four RCC cell lines, namely Caki-1, KU19-20, SW839 and Caki-2. Results: The PTEN expression in RCC was observed to decrease and p-Akt expression to increase significantly in comparison with that in the corresponding normal kidney tissue. The PTEN expression inversely correlated with the p-Akt expression. These alterations were specific for clear cell type RCC, but not for papillary or chromophobe type RCC. Alterations in Bad phosphorylation were also specifically observed in clear cell type. The Akt inhibitor induced apoptosis in KU19-20 and Caki-2 cells with a high Akt activity. Conclusions: A decreased expression of PTEN may be an underlying mechanism for Akt activation. An Akt inhibitor may be a therapeutic option for a subset of RCC with an elevated Akt activity.",
keywords = "Akt, Bad, PTEN, Renal cell carcinoma",
author = "S. Hara and Mototsugu Oya and Ryuichi Mizuno and A. Horiguchi and K. Marumo and M. Murai",
year = "2005",
month = "6",
doi = "10.1093/annonc/mdi182",
language = "English",
volume = "16",
pages = "928--933",
journal = "Annals of Oncology",
issn = "0923-7534",
publisher = "Oxford University Press",
number = "6",

}

TY - JOUR

T1 - Akt activation in renal cell carcinoma

T2 - Contribution of a decreased PTEN expression and the induction of apoptosis by an Akt inhibitor

AU - Hara, S.

AU - Oya, Mototsugu

AU - Mizuno, Ryuichi

AU - Horiguchi, A.

AU - Marumo, K.

AU - Murai, M.

PY - 2005/6

Y1 - 2005/6

N2 - Background: Akt has been implicated in the oncogenesis of human malignant tumors, because Akt regulates many key effector molecules involved in cell survival. PTEN (phosphatase and tensin homolog deleted on chromosome 10) negatively regulates Akt activation. Materials and methods: The expression of phosphorylated Akt (p-Akt), total Akt and PTEN was analyzed by Western blotting in 45 renal cell carcinoma (RCC) patients. The Bad and phosphorylated Bad (p-Bad) statuses were analyzed in 20 RCC patients. A phosphatidylinositol ether analog was used as an Akt inhibitor to treat four RCC cell lines, namely Caki-1, KU19-20, SW839 and Caki-2. Results: The PTEN expression in RCC was observed to decrease and p-Akt expression to increase significantly in comparison with that in the corresponding normal kidney tissue. The PTEN expression inversely correlated with the p-Akt expression. These alterations were specific for clear cell type RCC, but not for papillary or chromophobe type RCC. Alterations in Bad phosphorylation were also specifically observed in clear cell type. The Akt inhibitor induced apoptosis in KU19-20 and Caki-2 cells with a high Akt activity. Conclusions: A decreased expression of PTEN may be an underlying mechanism for Akt activation. An Akt inhibitor may be a therapeutic option for a subset of RCC with an elevated Akt activity.

AB - Background: Akt has been implicated in the oncogenesis of human malignant tumors, because Akt regulates many key effector molecules involved in cell survival. PTEN (phosphatase and tensin homolog deleted on chromosome 10) negatively regulates Akt activation. Materials and methods: The expression of phosphorylated Akt (p-Akt), total Akt and PTEN was analyzed by Western blotting in 45 renal cell carcinoma (RCC) patients. The Bad and phosphorylated Bad (p-Bad) statuses were analyzed in 20 RCC patients. A phosphatidylinositol ether analog was used as an Akt inhibitor to treat four RCC cell lines, namely Caki-1, KU19-20, SW839 and Caki-2. Results: The PTEN expression in RCC was observed to decrease and p-Akt expression to increase significantly in comparison with that in the corresponding normal kidney tissue. The PTEN expression inversely correlated with the p-Akt expression. These alterations were specific for clear cell type RCC, but not for papillary or chromophobe type RCC. Alterations in Bad phosphorylation were also specifically observed in clear cell type. The Akt inhibitor induced apoptosis in KU19-20 and Caki-2 cells with a high Akt activity. Conclusions: A decreased expression of PTEN may be an underlying mechanism for Akt activation. An Akt inhibitor may be a therapeutic option for a subset of RCC with an elevated Akt activity.

KW - Akt

KW - Bad

KW - PTEN

KW - Renal cell carcinoma

UR - http://www.scopus.com/inward/record.url?scp=21344446791&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=21344446791&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdi182

DO - 10.1093/annonc/mdi182

M3 - Article

VL - 16

SP - 928

EP - 933

JO - Annals of Oncology

JF - Annals of Oncology

SN - 0923-7534

IS - 6

ER -